Preventing Rh haemolytic disease.
D004334:Drug Administration Schedule; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007518:Isoantibodies / Q000008:administration & dosage; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System